Holloway, R.W.; Temkin, S.M.; Gordon, S.W.; Gupta, S.; Jada, S.R.; Ahmad, S.; McGuire, W.P.
A Phase Ib Study of Indirect Immunization with Oregovomab and Toll-like-Receptor-3 Stimulation with Hiltonol® in Patients with Recurrent Platinum-Resistant Ovarian Cancer. Curr. Oncol. 2025, 32, 532.
https://doi.org/10.3390/curroncol32100532
AMA Style
Holloway RW, Temkin SM, Gordon SW, Gupta S, Jada SR, Ahmad S, McGuire WP.
A Phase Ib Study of Indirect Immunization with Oregovomab and Toll-like-Receptor-3 Stimulation with Hiltonol® in Patients with Recurrent Platinum-Resistant Ovarian Cancer. Current Oncology. 2025; 32(10):532.
https://doi.org/10.3390/curroncol32100532
Chicago/Turabian Style
Holloway, Robert W., Sarah M. Temkin, Sarah W. Gordon, Sunil Gupta, Srinivasa R. Jada, Sarfraz Ahmad, and William P. McGuire.
2025. "A Phase Ib Study of Indirect Immunization with Oregovomab and Toll-like-Receptor-3 Stimulation with Hiltonol® in Patients with Recurrent Platinum-Resistant Ovarian Cancer" Current Oncology 32, no. 10: 532.
https://doi.org/10.3390/curroncol32100532
APA Style
Holloway, R. W., Temkin, S. M., Gordon, S. W., Gupta, S., Jada, S. R., Ahmad, S., & McGuire, W. P.
(2025). A Phase Ib Study of Indirect Immunization with Oregovomab and Toll-like-Receptor-3 Stimulation with Hiltonol® in Patients with Recurrent Platinum-Resistant Ovarian Cancer. Current Oncology, 32(10), 532.
https://doi.org/10.3390/curroncol32100532
